Joan E. Smallshaw - Search Results

Year	Number of Results
2002	1
2003	1
2004	2
2005	3
2006	3
2007	1
2010	2
2011	2
2012	2
2016	1
2024	0

1

Smallshaw JE, Vitetta ES. Smallshaw JE, et al. Curr Top Microbiol Immunol. 2012;357:259-72. doi: 10.1007/82_2011_156. Curr Top Microbiol Immunol. 2012. PMID: 21805396 Review.

2

The Immunogenicity of Peptoid-Protein Conjugates.

Case A, Desmond A, Lopes D, Dye K, Mapes K, Ruback S, Pop I, Kim JK, Chakravarty P, Smallshaw JE, Pop LM, Vitetta ES. Case A, et al. Among authors: smallshaw je. J Vaccines Vaccin. 2016 Aug;7(4):329. doi: 10.4172/2157-7560.1000329. Epub 2016 Jul 11. J Vaccines Vaccin. 2016. PMID: 27595050 Free PMC article.

3

Passive and active vaccination strategies to prevent ricin poisoning.

Pincus SH, Smallshaw JE, Song K, Berry J, Vitetta ES. Pincus SH, et al. Among authors: smallshaw je. Toxins (Basel). 2011 Sep;3(9):1163-84. doi: 10.3390/toxins3091163. Epub 2011 Sep 15. Toxins (Basel). 2011. PMID: 22069761 Free PMC article. Review.

4

Structure of RiVax: a recombinant ricin vaccine.

Legler PM, Brey RN, Smallshaw JE, Vitetta ES, Millard CB. Legler PM, et al. Among authors: smallshaw je. Acta Crystallogr D Biol Crystallogr. 2011 Sep;67(Pt 9):826-30. doi: 10.1107/S0907444911026771. Epub 2011 Aug 9. Acta Crystallogr D Biol Crystallogr. 2011. PMID: 21904036 Free PMC article.

5

Intradermal administration of RiVax protects mice from mucosal and systemic ricin intoxication.

Marconescu PS, Smallshaw JE, Pop LM, Ruback SL, Vitetta ES. Marconescu PS, et al. Among authors: smallshaw je. Vaccine. 2010 Jul 19;28(32):5315-22. doi: 10.1016/j.vaccine.2010.05.045. Epub 2010 Jun 1. Vaccine. 2010. PMID: 20562013 Free PMC article.

6

A lyophilized formulation of RiVax, a recombinant ricin subunit vaccine, retains immunogenicity.

Smallshaw JE, Vitetta ES. Smallshaw JE, et al. Vaccine. 2010 Mar 11;28(12):2428-35. doi: 10.1016/j.vaccine.2009.12.081. Epub 2010 Jan 12. Vaccine. 2010. PMID: 20074685 Free PMC article.

7

A novel recombinant vaccine which protects mice against ricin intoxication.

Smallshaw JE, Firan A, Fulmer JR, Ruback SL, Ghetie V, Vitetta ES. Smallshaw JE, et al. Vaccine. 2002 Sep 10;20(27-28):3422-7. doi: 10.1016/s0264-410x(02)00312-2. Vaccine. 2002. PMID: 12213413

8

Genetic engineering of an immunotoxin to eliminate pulmonary vascular leak in mice.

Smallshaw JE, Ghetie V, Rizo J, Fulmer JR, Trahan LL, Ghetie MA, Vitetta ES. Smallshaw JE, et al. Nat Biotechnol. 2003 Apr;21(4):387-91. doi: 10.1038/nbt800. Epub 2003 Mar 10. Nat Biotechnol. 2003. PMID: 12627168

9

Generation and characterization of a novel tetravalent anti-CD22 antibody with improved antitumor activity and pharmacokinetics.

Liu XY, Pop LM, Roopenian DC, Ghetie V, Vitetta ES, Smallshaw JE. Liu XY, et al. Among authors: smallshaw je. Int Immunopharmacol. 2006 May;6(5):791-9. doi: 10.1016/j.intimp.2005.11.022. Epub 2005 Dec 22. Int Immunopharmacol. 2006. PMID: 16546710

10

The generation and anti-myeloma activity of a chimeric anti-CD54 antibody, cUV3.

Smallshaw JE, Coleman E, Spiridon C, Vitetta ES. Smallshaw JE, et al. J Immunother. 2004 Nov-Dec;27(6):419-24. doi: 10.1097/00002371-200411000-00001. J Immunother. 2004. PMID: 15534485

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

17 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year